Ryoichi Maenosono

10PUBLICATIONS
38CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 02, 2026
Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer.

|May 20, 2026
Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan.

|May 10, 2026
Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study.

|Mar 15, 2026
The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy.

Takeshi Tsutsumi, Shogo Yamazaki, Takuya Matsuda

|Feb 02, 2026
Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan.

Keita Kobayashi, Kei Daizumoto, Takuya Tsujino

|Aug 20, 2025
Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study.

Takuhisa Nukaya, Kiyoshi Takahara, Shingo Toyoda

Pageof 2

Frequent Collaborators

5 joint publications

Wataru Fukuokaya

4 joint publications

Takafumi Yanagisawa

4 joint publications

Takahiro Kimura

4 joint publications

Kazutoshi Fujita